Union Health Minister Dr Mansukh Mandaviya review status of essential medicines and drugs with Pharma Companies in view of spike in COVID19 cases in some countries

Union Minister of Health & Family Welfare and Chemicals & Fertilizers, Dr. Mansukh Mandaviya reviewed the status, adequacy of COVID management drugs and production capacities with representatives of pharma companies through a VC, here today, so that India is equipped to effectively handle any situation. This review meeting was taken in view of the spike in COVID19 cases in some countries worldwide.

Through a presentation, the Union Minister was briefed regarding the evolving global scenario. Dr Mansukh Mandaviya appreciated and congratulated the pharma companies for their invaluable contribution during the COVID pandemic in the country.

“India’s pharmaceutical industry is robust, resilient and responsive. It is due to their strength that we could not only meet our down demand during the pandemic, but also be in a position to supply medicines to 150 countries.” This was achieved without any fall in quality and no hike in the price of the medicines, he stressed.